PMN-MDSC and arginase are increased in myeloma and may contribute to resistance to therapy.
Romano A, Parrinello NL, La Cava P, Tibullo D, Giallongo C, Camiolo G, Puglisi F, Parisi M, Pirosa MC, Martino E, Conticello C, Palumbo GA, Di Raimondo F.
Romano A, et al. Among authors: giallongo c.
Expert Rev Mol Diagn. 2018 Jul;18(7):675-683. doi: 10.1080/14737159.2018.1470929. Epub 2018 May 3.
Expert Rev Mol Diagn. 2018.
PMID: 29707981